International Consensus on Use of Continuous Glucose Monitoring

Cited by (1,003)

Items 201–300 of 1,003

1. Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression
   Musso, Giovanni, Sircana, Antonio, Saba, Francesca, Cassader, Maurizio, Gambino, Roberto · 2020 · PLOS Medicine
2. Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study
   Torben Biester, Ido Muller, Thekla von dem Berge, Eran Atlas, Revital Nimri, Moshe Phillip, Tadej Battelino, Nataša Bratina, Klemen Dovč, Markus Florian Scheerer et al. · 2020 · Diabetes Obesity and Metabolism
3. Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?
   Louis Monnier, Anne Wojtusciszyn, Nicolas Molinari, C Colette, Éric Renard, David R. Owens · 2020 · Diabetes Care
4. Glucose Variability and Diabetic Complications: Is It Time to Treat?
   Antonio Ceriello · 2020 · Diabetes Care
5. The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial
   Kristine Færch, Martin Bæk Blond, Lea Bruhn, Hanan Amadid, Dorte Vistisen, Kim Katrine Bjerring Clemmensen, Camilla Trine Ravn Vainø, CAMILLA HARTMANN PEDERSEN, Maria Tvermosegaard, Thomas Fremming Dejgaard et al. · 2020 · Diabetologia
6. MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial
   Vera Novak, Christos Socrates Mantzoros, Péter Novák, Regina E. McGlinchey, Weiying Dai, Vasileios‐Arsenios Lioutas, Stephanie S. Buss, Catherine B. Fortier, Faizan Ahmad Khan, Laura Aponte Becerra et al. · 2022 · Journal of Neurology
7. The Glucose Management Indicator: Time to Change Course?
   Elizabeth Selvin · 2024 · Diabetes Care
8. Estimation of hemoglobin A1c from continuous glucose monitoring data in individuals with type 1 diabetes: is time in range all we need?
   Fabris, Chiara, Heinemann, Lutz, Beck, Roy, Cobelli, Claudio, Kovatchev, Boris · 2020 · Diabetes Technology & Therapeutics
9. Digital Technology for Diabetes
   Hughes, Michael S., Addala, Ananta, Buckingham, Bruce · 2023 · New England Journal of Medicine
10. Metas no tratamento do diabetes
    Bianca de Almeida-Pititto, Monike Lourenço Dias Rodrigues, Fabio Ferreira de Moura, Rodrigo Nunes Lamounier, Sérgio Alberto Cunha Vencio, Luís Eduardo Calliari, Marcello Casaccia Bertoluci · 2022 · Conectando Pessoas eBooks
11. β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL
    Sarah C. Nyirjesy, Saba Sheikh, Denis Hadjiliadis, Diva D. De León, Amy J. Peleckis, Jack N. Eiel, Christina Kubrak, Darko Stefanovski, Ronald C. Rubenstein, Michael Roehrhoff Rickels et al. · 2018 · Pediatric Diabetes
12. Efficacy of the Flexible Lifestyles Empowering Change intervention on metabolic and psychosocial outcomes in adolescents with type 1 diabetes (FLEX): a randomised controlled trial
    Elizabeth J. Mayer‐Davis, David M. Maahs, Michael Seid, Jamie Crandell, Franziska K. Bishop, Kimberly A. Driscoll, Christine M. Hunter, Jessica Kichler, Debra A. Standiford, Joan M Thomas et al. · 2018 · The Lancet Child & Adolescent Health
13. Hemodialysis-Related Glycemic Disarray Proven by Continuous Glucose Monitoring; Glycemic Markers and Hypoglycemia
    Akinori Hayashi, Naoya Shimizu, Agena Suzuki, Kenta Matoba, Akari Momozono, Tsuguto Masaki, Akifumi Ogawa, Ibuki Moriguchi, Koji Takano, Naoyuki Kobayashi et al. · 2021 · Diabetes Care
14. Expert Guidance on Off-Label Use of Hybrid Closed-Loop Therapy in Pregnancies Complicated by Diabetes
    Emily Deborah Szmuilowicz, Carol Joan Levy, Elizabeth Buschur, Sarit Polsky · 2023 · Diabetes Technology & Therapeutics
15. High-Intensity Interval Training Improves Aerobic Capacity Without a Detrimental Decline in Blood Glucose in People With Type 1 Diabetes
    Sam N. Scott, Matthew S. Cocks, Robert Charles Andrews, Parth Narendran, Tejpal Singh Purewal, Daniel James Cuthbertson, Anton J. M. Wagenmakers, Sam O. Shepherd · 2018 · The Journal of Clinical Endocrinology & Metabolism
16. Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the “Gordian Knot”?
    Louis Monnier, C Colette, David R. Owens · 2021 · Diabetes & Metabolism
17. Continuous glucose monitoring defined glucose variability is associated with cardiovascular autonomic neuropathy in type 1 diabetes
    Ji Eun Jun, Seung‐Eun Lee, You‐Bin Lee, Ji Yeon Ahn, Gyuri Kim, Kyu Yeon Hur, Moon‐Kyu Lee, Sang‐Man Jin, Jae Hyeon Kim · 2018 · Diabetes/Metabolism Research and Reviews
18. Time in Range for Multiple Technologies in Type 1 Diabetes: A Systematic Review and Network Meta-analysis
    Anthony Pease, Clement Lo, Arul Earnest, Velislava Kiriakova, Danny Liew, Sophia Zoungas · 2020 · Diabetes Care
19. Sleep and diabetes‐specific psycho‐behavioral outcomes of a new automated insulin delivery system in young children with type 1 diabetes and their parents
    Alessandro Bisio, Sue A. Brown, Ryan K. McFadden, Michael Pajewski, Pearl L. Yu, Mark Daniel DeBoer, Melissa J. Schoelwer, Heather Bonner, CHRISTIAN A. WAKEMAN, Daniel R. Cherñavvsky et al. · 2020 · Pediatric Diabetes
20. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial
    Furler, John, O'Neal, David, Speight, Jane, Blackberry, Irene, Manski-Nankervis, Jo-Anne, Thuraisingam, Sharmala, de La Rue, Katie, Ginnivan, Louise, Doyle, Rebecca, Holmes-Truscott, Elizabeth et al. · 2020 · The Lancet Diabetes & Endocrinology
21. Machine-Learning Based Model to Improve Insulin Bolus Calculation in Type 1 Diabetes Therapy
    Noaro, Giulia, Cappon, Giacomo, Vettoretti, Martina, Sparacino, Giovanni, Favero, Simone Del, Facchinetti, Andrea · 2021 · IEEE Transactions on Biomedical Engineering
22. Amelioration of user experiences and glycaemic outcomes with an Advanced Hybrid Closed Loop System in a real-world clinical setting
    Pilar Isabel Beato-Víbora, Fabiola Gallego-Gamero, Ana Ambrojo-López, Estela Gil-Poch, Irene Martín-Romo, Francisco Javier Arroyo-Díez · 2021 · Diabetes Research and Clinical Practice
23. Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System
    Dorothee Deiss, Agnieszka Szadkowska, Debbie Gordon, Akhila Mallipedhi, Ingrid Schütz-Fuhrmann, Eva Aguilera, Corina Ringsell, Christophe E.M. De Block, Concetta Irace · 2019 · Diabetes Technology & Therapeutics
24. Pathophysiology and management of diabetic gastroenteropathy
    Theresa Meldgaard, Jutta Keller, Anne Estrup Olesen, Søren Schou Olesen, Klaus Krogh, Mette Borre, Adam Donald Farmer, Birgitte Brock, Christina Brock, Asbjørn Mohr Drewes · 2019 · Therapeutic Advances in Gastroenterology
25. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes
    Goran Petrovski, Fawziya Al Khalaf, Judith Campbell, Fareeda Umer, Douha Almajaly, Manar Hamdan, Khalid Hussain · 2020 · Acta Diabetologica
26. Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers
    Laya Ekhlaspour, Melissa J. Schoelwer, Gregory P. Forlenza, Mark Daniel DeBoer, Lisa Norlander, Liana J. Hsu, RYAN S. KINGMAN, Emily Boranian, Cari Berget, Emma G. Emory et al. · 2020 · Diabetes Technology & Therapeutics
27. Reference Guide for Integrating Continuous Glucose Monitoring Into Clinical Practice
    Kruger, Davida F., Edelman, Steve V., Hinnen, Deborah A., Parkin, Christopher G. · 2019 · The Diabetes Educator
28. Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes
    James J. Chamberlain, Kacie Doyle-Delgado, Lacie Peterson, NEIL SKOLNIK · 2019 · Annals of Internal Medicine
29. Continuous glucose monitoring and use of alternative markers to assess glycemia in chronic kidney disease
    Zelnick, Leila R., Batacchi, Zona O., Ahmad, Iram, Dighe, Ashveena, Little, Randie R., Trence, Dace L., Hirsch, Irl B., de Boer, Ian H. · 2020 · Diabetes Care
30. Algorithms for Automated Insulin Delivery: An Overview
    Andreas Thomas, Lutz Heinemann · 2021 · Journal of Diabetes Science and Technology
31. Diabetes mellitus type 2 in adults
    Ivan Ivanovich Dedov, Marina Vladimirovna Shestakova, Alexander Yu. Mayorov, Минара Шамхаловна Шамхалова, Olga Yu. Sukhareva, Gagik Radikovich Galstyan, Alla Yur'evna Tokmakova, Tatiana Vasil'evna Nikonova, Elena Viktorovna Surkova, Ирина Владимировна Кононенко et al. · 2020 · Diabetes Mellitus
32. Differential Glycemic Effects of Low- versus High-Glycemic Index Mediterranean-Style Eating Patterns in Adults at Risk for Type 2 Diabetes: The MEDGI-Carb Randomized Controlled Trial
    Robert Emerson Bergia, Rosalba Giacco, Thérése Hjorth, Izabela Biskup, Wenbin Zhu, Giuseppina Costabile, Marilena Vitale, Wayne W. Campbell, Rikard Landberg, Gabriele Riccardi · 2022 · Nutrients
33. Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial
    Margaretha M. Visser, Sara Charleer, Steffen Fieuws, Christophe E.M. De Block, Robert Hilbrands, Liesbeth Van Huffel, Toon Maes, Gerd Vanhaverbeke, Eveline Lia Dirinck, Nele Myngheer et al. · 2023 · The Lancet Diabetes & Endocrinology
34. Improving patient self-care using diabetes technologies
    Valeria Alcántara-Aragón · 2019 · Therapeutic Advances in Endocrinology and Metabolism
35. Prediction of Nocturnal Hypoglycemia From Continuous Glucose Monitoring Data in People With Type 1 Diabetes: A Proof-of-Concept Study
    Morten Hasselstrøm Jensen, Claus Dethlefsen, Peter Vestergaard, Ole Kristian Hejlesen · 2019 · Journal of Diabetes Science and Technology
36. Time in range: A best practice guide for UK diabetes healthcare professionals in the context of the COVID‐19 global pandemic
    Emma G. Wilmot, Alistair N. Lumb, Peter J. Hammond, Helen R. Murphy, ELEANOR M. SCOTT, Fraser W. Gibb, Julia K. Platts, Pratik Choudhary · 2020 · Diabetic Medicine
37. Elevations in blood glucose before and after the appearance of islet autoantibodies in children
    Katharina Warncke, Andreas Weiß, Peter Achenbach, Thekla von dem Berge, Reinhard Berner, Kristina Casteels, Lidia Groele, Konstantinos Hatzikotoulas, Angela Hommel, Olga Kordonouri et al. · 2022 · Journal of Clinical Investigation
38. Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: A systematic review and meta-analysis
    Anna Hjort, David Iggman, Fredrik Rosqvist · 2024 · Clinical Nutrition
39. Time In Range in Children with Type 1 Diabetes Using Treatment Strategies Based on Nonautomated Insulin Delivery Systems in the Real World
    Valentino Cherubini, Riccardo Bonfanti, Alberto Casertano, Elena De Nitto, Antonio Iannilli, Fortunato Lombardo, Giulio Maltoni, Marco Marigliano, Marta Bassi, Nicola Minuto et al. · 2020 · Diabetes Technology & Therapeutics
40. Artificial pancreas under stable pulsatile MPC: Improving the closed-loop performance
    Pablo Abuin, Pablo S. Rivadeneira, Antonio Ferramosca, Alejandro H. González · 2020 · Journal of Process Control
41. Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: The Maastricht Study
    Yuri D. Foreman, William P. T. M. van Doorn, Nicolaas C. Schaper, Marleen M. J. van Greevenbroek, Carla Kallen, Ronald M.A. Henry, Annemarie Koster, Simone J. P. M. Eussen, Anke Wesselius, Koen D. Reesink et al. · 2021 · Diabetologia
42. Considerations to address missing data when deriving clinical trial endpoints from digital health technologies
    Junrui Di, Charmaine Demanuele, Anna E. Kettermann, F. Işık Karahanoğlu, Joseph C. Cappelleri, Andrew Potter, Denise P. Bury, Jesse M. Cedarbaum, Bill Byrom · 2021 · Contemporary Clinical Trials
43. The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)
    Shilan Seyed Ahmadi, Klara Westman, Aldina Pivodic, Arndís Finna Ólafsdóttir, Sofia Dahlqvist, Irl B. Hirsch, Jarl Hellman, Magnus Ekelund, Tim Heise, William H. Polonsky et al. · 2020 · Diabetes Care
44. Expert panel guidance and narrative review of treatment simplification of complex insulin regimens to improve outcomes in type 2 diabetes
    Jude, Edward B., Malecki, Maciej T., Gomez Huelgas, Ricardo, Prazny, Martin, Snoek, Frank, Tankova, Tsvetalina, Giugliano, Dario, Khunti, Kamlesh · 2022 · Diabetes Therapy
45. Clinical recommendations for the use of the ambulatory glucose profile in diabetes care
    Kröger, Jens, Reichel, Andreas, Siegmund, Thorsten, Ziegler, Ralph · 2020 · Journal of Diabetes Science and Technology
46. A Review of Continuous Glucose Monitoring-Based Composite Metrics for Glycemic Control
    Michelle Nguyen, Julia L. Han, Elias K. Spanakis, Boris P. Kovatchev, David Charles Klonoff · 2020 · Diabetes Technology & Therapeutics
47. Monitoring of Pediatric Type 1 Diabetes
    Brynn E. Marks, Joseph I. Wolfsdorf · 2020 · Frontiers in Endocrinology
48. Improving Clinical Outcomes in Newly Diagnosed Pediatric Type 1 Diabetes: Teamwork, Targets, Technology, and Tight Control—The 4T Study
    Priya Prahalad, Dessi P. Zaharieva, Ananta Addala, Christin New, David Scheinker, Manisha Desai, Korey K. Hood, David M. Maahs · 2020 · Frontiers in Endocrinology
49. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy
    Miriam Longo, Paola Caruso, Michela Petrizzo, Filomena Castaldo, Annalisa Sarnataro, Maurizio Gicchino, Giuseppe Bellastella, Katherine Esposito, Maria Ida Maiorino · 2020 · Diabetes Research and Clinical Practice
50. Perspectives of glycemic variability in diabetic neuropathy: a comprehensive review
    Xiaochun Zhang, Xue Qin Yang, Bao Sun, Chunsheng Zhu · 2021 · Communications Biology
51. Hypoglycemia: New Definitions and Regulatory Implications
    Robert E. Ratner · 2018 · Diabetes Technology & Therapeutics
52. Therapy Adjustments Based on Trend Arrows Using Continuous Glucose Monitoring Systems
    Ralph Ziegler, Simone von Sengbusch, Jens Kröger, Oliver Schubert, Petra Werkmeister, Dorothee Deiss, Thorsten Siegmund · 2019 · Journal of Diabetes Science and Technology
53. Hypoglycaemia detection and prediction techniques: A systematic review on the latest developments
    Omar Diouri, Monika Cigler, Martina Vettoretti, Julia Katharina Mader, Pratik Choudhary, Éric Renard · 2021 · Diabetes/Metabolism Research and Reviews
54. Glycemic variability modifies the relationship between time in range and hemoglobin A1c estimated from continuous glucose monitoring: a preliminary study
    Lu, Jingyi, Ma, Xiaojing, Zhang, Lei, Mo, Yifei, Lu, Wei, Zhu, Wei, Bao, Yuqian, Jia, Weiping, Zhou, Jian · 2020 · Diabetes Research and Clinical Practice
55. Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes
    Klemen Dovč, Stefanie Lanzinger, Roque Cardona‐Hernandez, Martin Tauschmann, Marco Marigliano, Valentino Cherubini, Romualdas Tomas Preikša, Ulrike Helga Elisabeth Schierloh, Helen F. Clapin, Fahed Aljaser et al. · 2023 · JAMA Network Open
56. Wearable and digital devices to monitor and treat metabolic diseases
    Ayya Keshet, Lee Reicher, Noam Bar, Eran Segal · 2023 · Nature Metabolism
57. Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems
    Manuel Eichenlaub, Stefan Pleus, Martina Rothenbühler, Timothy Silleck Bailey, Lia Bally, Ronald Brazg, Daniela Bruttomesso, Peter Diem, Elisabet Eriksson Boija, Marion J. Fokkert et al. · 2024 · Diabetes Technology & Therapeutics
58. Fasted High-Intensity Interval and Moderate-Intensity Exercise Do Not Lead to Detrimental 24-Hour Blood Glucose Profiles
    Sam N. Scott, Matthew S. Cocks, Robert Charles Andrews, Parth Narendran, Tejpal Singh Purewal, Daniel James Cuthbertson, Anton J. M. Wagenmakers, Sam O. Shepherd · 2018 · The Journal of Clinical Endocrinology & Metabolism
59. Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes
    Irl B. Hirsch, Jennifer L. Sherr, Korey K. Hood · 2019 · Diabetes Care
60. Hypoglycemia in People with Type 2 Diabetes and CKD
    Iram Ahmad, Leila R. Zelnick, Zona O. Batacchi, Nicole Robinson, Ashveena L. Dighe, Jo-Anne Elizabeth Manski-Nankervis, John Furler, David Norman O'Neal, Randie R. Little, Dace Trence et al. · 2019 · Clinical Journal of the American Society of Nephrology
61. Immediate post-breakfast physical activity improves interstitial postprandial glycemia: a comparison of different activity-meal timings
    Thomas P. J. Solomon, Eloise Kate Tarry, Chloe O. Hudson, Alice I. Fitt, Matthew James Laye · 2019 · Pflügers Archiv - European Journal of Physiology
62. Continuous glucose monitoring in cystic fibrosis – A practical guide
    Christine L. Chan, Katie Larson Ode, Andrea Granados, Amir A. Moheet, Antoinette Moran, Shihab Ahmed Hameed · 2019 · Journal of Cystic Fibrosis
63. A review of biosensor technology and algorithms for glucose monitoring
    Yaguang Zhang, Jingxue Sun, Liansheng Liu, Hong Qiao · 2021 · Journal of Diabetes and its Complications
64. Use of Technology in Older Adults with Type 1 Diabetes: Clinical Characteristics and Glycemic Metrics
    Medha N. Munshi, Christine Slyne, DAI’QUANN J. DAVIS, Amy Lynn Michals, Kayla Sifre, Rachel Dewar, Astrid Atakov-Castillo, Elena Toschi · 2021 · Diabetes Technology & Therapeutics
65. Wearable Bifocal Contact Lens for Continual Glucose Monitoring Integrated with Smartphone Readers
    Mohamed Elsherif, Fahad Alam, Ahmed E. Salih, Bader AlQattan, Ali K. Yetisen, Haider Butt · 2021 · Small
66. Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2
    Chantal Mathieu, Paresh Dandona, Moshe Phillip, Tal Oron, Marcus Lind, Lars Hansen, FREDRIK A. THOREN, John L. Xu, Anna Maria Langkilde, on behalf of the DEPICT-1 and DEPICT-2 Investigators · 2019 · Diabetes Care
67. Vascular Complication in Adolescents With Diabetes Mellitus
    Lara E. Graves, Kim C. Donaghue · 2020 · Frontiers in Endocrinology
68. Efficacy and safety of glimepiride with or without linagliptin treatment in patients with HNF1A diabetes (maturity-onset diabetes of the young type 3): a randomized, double-blinded, placebo-controlled, crossover trial (GLIMLINA)
    Christensen, Alexander S., Hædersdal, Sofie, Støy, Julie, Storgaard, Heidi, Kampmann, Ulla, Forman, Julie L., Seghieri, Marta, Holst, Jens J., Hansen, Torben, Knop, Filip K. et al. · 2020 · Diabetes Care
69. Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: a cross-sectional population study of children with type 1 diabetes in New Zealand
    Mercedes J. Burnside, Jonathan A. Williman, Hannah M Davies, Craig Jefferies, Ryan G. Paul, Benjamin John Wheeler, Esko J. Wiltshire, Yvonne C. Anderson, Martin I. de Bock · 2022 · The Lancet Regional Health - Western Pacific
70. Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care
    Thomas Danne, Torben Biester, Olga Kordonouri · 2018 · Diabetes Technology & Therapeutics
71. Advances in Type 1 Diabetes Technology Over the Last Decade
    Chelsea F. Zimmerman, Anastasia Albanese-O’Neill, Michael J. Haller · 2019 · touchREVIEWS in Endocrinology
72. Effects of Exercise on Blood Glucose and Glycemic Variability in Type 2 Diabetic Patients with Dawn Phenomenon
    Xin Sally Zheng, Yanyan Qi, Lina Bi, Wenli Shi, Yan Zhang, Dan Zhao, Su Hu, Meixin Li, Qin Li · 2020 · BioMed Research International
73. A Novel Luminescent “Nanochip” as a Tandem Catalytic System for Chemiluminescent Detection of Sweat Glucose
    Ya Gao, Yu Huang, Jianmei Chen, Yuhang Liu, Yurui Xu, Xinghai Ning · 2021 · Analytical Chemistry
74. CGMS and Glycemic Variability, Relevance in Clinical Research to Evaluate Interventions in T2D, a Literature Review
    Anne-Esther Breyton, S. Lambert-Porcheron, Martine Laville, Sophie Vinoy, Julie‐Anne Nazare · 2021 · Frontiers in Endocrinology
75. Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes
    Satomi Wakasugi, Tomoya Mita, Naoto Katakami, Yosuke Okada, Hidenori Yoshii, Takeshi Osonoi, Keiko Nishida, Toshihiko Shiraiwa, Keiichi Torimoto, Akira Kurozumi et al. · 2021 · BMJ Open Diabetes Research & Care
76. Real‐world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed‐loop use
    Cari Berget, Halis Kaan Aktürk, Laurel H. Messer, Tim Vigers, Laura L. Pyle, Janet K. Snell‐Bergeon, Kimberly A. Driscoll, Gregory P. Forlenza · 2021 · Diabetes Obesity and Metabolism
77. Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future
    Thomas Danne, Catarina Limbert, Manel Puig‐Domingo, Stefano Del Prato, Éric Renard, Pratik Choudhary, Alexander Seibold · 2021 · Diabetes Therapy
78. Impact of short-term glycemic variability on risk of all-cause mortality in type 2 diabetes patients with well-controlled glucose profile by continuous glucose monitoring: A prospective cohort study
    Yifei Mo, Chunfang Wang, Jingyi Lu, Yun Shen, Lei Chen, Lei Zhang, Wei Lu, Wei Zhu, Tian Xia, Jian Zhou · 2022 · Diabetes Research and Clinical Practice
79. Management of diabetes complications in youth
    Lara E. Graves, Kim C. Donaghue · 2019 · Therapeutic Advances in Endocrinology and Metabolism
80. Impact of COVID-19 Lockdown on Glycemic Control in Adults with Type 1 Diabetes Mellitus
    Begoña Pla, Alfonso Arranz, Carolina Knott-Torcal, Miguel Sampedro, Sara Jiménez, Iñigo Hernando Alday, Mónica Marazuela · 2020 · Journal of the Endocrine Society
81. Anticipation of Historical Exercise Patterns by a Novel Artificial Pancreas System Reduces Hypoglycemia During and After Moderate-Intensity Physical Activity in People with Type 1 Diabetes
    José Garcia‐Tirado, Sue A. Brown, Nitchakarn Laichuthai, Patricio H. Colmegna, Chaitanya L.K. Koravi, Başak Özaslan, John P. Corbett, Charlotte L. Barnett, Michael Pajewski, Mary Clancy Oliveri et al. · 2020 · Diabetes Technology & Therapeutics
82. A Comprehensive Review of Continuous Glucose Monitoring Accuracy during Exercise Periods
    Elena Muñoz Fabra, José-Luis Díez, Jorge Bondía, Alejandro José Laguna Sanz · 2021 · Sensors
83. Thresholds of Glycemia and the Outcomes of COVID-19 Complicated With Diabetes: A Retrospective Exploratory Study Using Continuous Glucose Monitoring
    Yun Shen, Xiaohong Fan, Lei Zhang, Yaxin Wang, Cheng Li, Jingyi Lu, Bingbing Zha, Yueyue Wu, Xiaohua Chen, Jian Zhou et al. · 2021 · Diabetes Care
84. Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes
    Andrzej Gawrecki, Dorota Zozulińska‐Ziółkiewicz, Magdalena Michalak, Anna Adamska, Michał Michalak, Urszula Frąckowiak, Justyna Flotyńska, Monika Pietrzak, Szymon Czapla, Bernhard Gehr et al. · 2021 · PLoS ONE
85. Time-in-range for monitoring glucose control: Is it time for a change?
    Virginia Bellido, Pedro José Pinés-Corrales, Rocío Villar‐Taibo, Francisco Javier Ampudia‐Blasco · 2021 · Diabetes Research and Clinical Practice
86. Advanced hybrid artificial pancreas system improves on unannounced meal response - In silico comparison to currently available system
    José Garcia‐Tirado, Dayu Lv, John P. Corbett, Patricio H. Colmegna, Marc D. Breton · 2021 · Computer Methods and Programs in Biomedicine
87. Equitable implementation of a precision digital health program for glucose management in individuals with newly diagnosed type 1 diabetes
    Priya Prahalad, David Scheinker, Manisha Desai, Victoria Y. Ding, Franziska K. Bishop, Ming Yeh Lee, Johannes O. Ferstad, Dessi P. Zaharieva, Ananta Addala, Ramesh Johari et al. · 2024 · Nature Medicine
88. Hemoglobin A1c Trajectory in Pediatric Patients with Newly Diagnosed Type 1 Diabetes
    Priya Prahalad, Jaden Yang, David Scheinker, Manisha Desai, Korey K. Hood, David M. Maahs · 2019 · Diabetes Technology & Therapeutics
89. A Review of Research Progress on Glycemic Variability and Gestational Diabetes
    Yu, Wenshu, Wu, Na, Li, Ling, OuYang, Hong, Qian, Meichen, Shen, Haitao · 2020 · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
90. CGM accuracy: Contrasting CE marking with the governmental controls of the USA ( FDA ) and Australia ( TGA ): A narrative review
    Pemberton, John S, Wilmot, Emma G, Barnard‐Kelly, Katharine, Leelarathna, Lalantha, Oliver, Nick, Randell, Tabitha, Taplin, Craig E, Choudhary, Pratik, Adolfsson, Peter · 2023 · Diabetes, Obesity and Metabolism
91. Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study
    Andreas Andersen, Jonatan Ising Bagger, Samuel Kiil Sørensen, MARIA POMPEA ANTONIA BALDASSARRE, Ulrik Pedersen‐Bjergaard, Julie Lyng Forman, Gunnar Gislason, Tommi Bo Lindhardt, Filip Krag Knop, Tina Vilsbøll · 2021 · Cardiovascular Diabetology
92. Comparative assessment of blood glucose monitoring techniques: a review
    Nivad Ahmadian, Annamalai Manickavasagan, Amanat Ali · 2022 · Journal of Medical Engineering & Technology
93. Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter?
    Yifei Mo, Jingyi Lu, Jian Zhou · 2023 · Journal of Diabetes Investigation
94. Ketogenic diet but not free-sugar restriction alters glucose tolerance, lipid metabolism, peripheral tissue phenotype, and gut microbiome: RCT
    Aaron Hengist, Russell G. Davies, Jean‐Philippe Walhin, Jariya Buniam, Lucy H. Merrell, L M Rogers, Louise Bradshaw, Alfonso Moreno‐Cabañas, Peter J. Rogers, Jeffrey M. Brunstrom et al. · 2024 · Cell Reports Medicine
95. Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus
    Ana María Gómez, Óscar Múñoz, Alejandro Marín Sánchez, Maria Camila Fonseca, Martín Rondón, María Alejandra Robledo Gómez, Andrey Alexandrovich Sanko, Dilcia Luján, G. Maira, Fabian Mauricio León Vargas · 2018 · Journal of Diabetes Science and Technology
96. Standards of Specialized Diabetes Care / Edited by Dedov I.I., Shestakova M.V., Sukhareva O.Yu. 12th Edition
    I. Dedov, M. Shestakova, O. Sukhareva, N. Mokrysheva, E. Andreeva, O. Bezlepkina, V. Peterkova, E. Artemova, P. Bardiugov, E. Bessmertnaya et al. · 2025 · Diabetes Mellitus
97. Time in range in pregnancy: is there a role?
    Wyckoff, Jennifer A., Brown, Florence M. · 2021 · Diabetes Spectrum
98. Closed-loop insulin delivery: update on the state of the field and emerging technologies
    Julia Ware, Roman Hovorka · 2022 · Expert Review of Medical Devices
99. Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study
    Matthew C. Riddle, Rajaa Nahra, Jenny Han, Jessica R. Castle, Kathryn Hanavan, Marcus Hompesch, David M. Huffman, Poul Strange, Peter Öhman · 2018 · Diabetes Care
100. Hypoglycemia and glycemic control in older adults with type 1 diabetes: baseline results from the WISDM study
     Carlson, Anders L., Kanapka, Lauren G., Miller, Kellee M., Ahmann, Andrew J., Chaytor, Naomi S., Fox, Steven, Kiblinger, Lisa, Kruger, Davida, Levy, Carol J., Peters, Anne L. et al. · 2021 · Journal of Diabetes Science and Technology